✦ LIBER ✦

Perspective on Potential Clinical Applications of Recombinant Human Interleukin-7

✍ Scribed by Claude Sportès; Ronald E. Gress; Crystal L. Mackall

Book ID: 111756785
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 409 KB
Volume: 1182
Category: Article
ISSN: 0890-6564
DOI: 10.1111/j.1749-6632.2009.05075.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of recombinant human interleuk

Influence of recombinant human interleukin (IL)-7 on disease progression in mice infected with friend virus complex

✍ Li Lu; Zhen Zhou; Bo Wu; Mang Xiao; Rong-Nian Shen; Douglas E. Williams; Young-J 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 821 KB

Recombinant human (rhu) IL-7 was evaluated for its influence on disease progression in mice infected with the polycythemiainducing strain of the Friend virus complex (FVC). D B A I I mice were injected i.v. with FVC, and then treated S.C. with rhulL-7. IL-7 significantly prolonged survival time and

Potential of on-line isotachophoresis-ca

Potential of on-line isotachophoresis-capillary zone electrophoresis with hydrodynamic counterflow in the analysis of various basic proteins and recombinant human interleukin-3

✍ J. Bergmann; U. Jaehde; M. Mazereeuw; U.R. Tjaden; W. Schunack 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 558 KB

Development of a human cell assay to ass

Development of a human cell assay to assess the impact of environmental pollutants on human health: Potential application in clinical laboratories

✍ K. Adeli; F.N. Ali; G.D. Haffner 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Renal differentiation of amniotic fluid

Renal differentiation of amniotic fluid stem cells: perspectives for clinical application and for studies on specific human genetic diseases

✍ Margit Rosner; Katharina Schipany; Claudia Gundacker; Bharanidharan Shanmugasund 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Development of LC/MS/MS assay for the de

Development of LC/MS/MS assay for the determination of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-1-sulfonyl]-2-propoxyphenyl}-7-propyl-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one (SK3530) in human plasma: application to a clinical pharmacokinetic study

✍ Beom Soo Shin; Seul Ki Hu; John Kim; Joon Gyo Oh; Won-No Youn; Bongyong Lee; Key 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 876 KB